Intensification of Therapeutic Approaches Reduces Mortality in Diabetic Patients with Acute Myocardial Infarction: The Munich registry

Diabetes Care

Volumn 27, Issue 2, 2004, Pages 455-460

  Schnell, Oliver ^a,b   Schäfer, Oliver ^a   Kleybrink, Sonja ^a   Doering, Wittich ^a   Standl, Eberhard ^a   Otter, Wolfgang ^a  

^a Klinikum Schwabing   (Germany)

^b INSTITUT FÜR DIABETESFORSCHUNG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; INSULIN; STATINE DERIVATIVE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; CRITICAL ILLNESS; DATA ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; FEMALE; GERMANY; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GLUCOSE METABOLISM; HEALTH CARE QUALITY; HUMAN; INSULIN INFUSION; INSULIN TREATMENT; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; PATIENT CARE; REGISTER; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; DIABETIC ANGIOPATHIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MYOCARDIAL INFARCTION; RISK FACTORS; STENTS; SURVIVAL ANALYSIS;

EID: 0842311538     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.2.455     Document Type: Article

References (23)

1. Standl E, Schnell O: A new look at the heart in diabetes mellitus: from ailing to failing. Diabetologia 43:1455-1469, 2000
2. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23: 105-111, 1974
3. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229-234, 1998
4. Loewel H, Koenig W, Engel S, Hormann A, Keil U: The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologia 43:218-226, 2000
5. Yudkin JS, Oswald GA: Determinants of hospital admission and case fatality in diabetic patients with myocardial infarction. Diabetes Care 11:351-358, 1988
6. Granger CB, Califf RM, Young S, Candela R, Samaha J, Worley S, Kereiakes DJ, Topol EJ: Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents: the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. J Am Coll Cardiol 21:920-925, 1993
7. Norhammar A, Malmberg K, Ryden L, Tornvall P, Stenestrand U, Wallentin L: Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA): under utilisation of evidence-based treatment partially explains for the unfavourable prognosis in diabetic patients with acute myocardial infarction. Eur Heart J 24:838-844, 2003
8. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Venvaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31:359-366, 2003
9. Malmberg K, Norhammar A, Wedel H, Ryden L: Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99:2626-2632, 1999
10. Malmberg K: Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus: DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. BMJ 314:1512-1515, 1997
11. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Alpert JS, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SCJr: ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36:970-1062, 2000
12. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE 3rd, Steward DE, Theroux P, Gibbons RJ, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Smith SC Jr: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 40: 1366-1374, 2002
13. Guidelines Subcommittee: 1999 World Health Organization-International Society of Hypertension guidelines for the management of Hypertension. J Hypertens 17:151-183, 1999
14. Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778, 2000
15. Bolk J, van der PT, Cornel JH, Arnold AE, Sepers J, Umans VA: Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol 79:207-214, 2001
16. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K: Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144, 2002
17. Malmberg K, McGuire DK. Diabetes and acute myocardial infarction: the role of insulin therapy. Am Heart J 138:S381-S386
18. Sack MN, Yellon DM: Insulin therapy as an adjunct to reperfusion after acute myocardial infarction. J Am Coll Cardiol 41: 1404-1407, 2003
19. Das UN: Is insulin an endogenous cardio-protector? Crit Care 6:389-393, 2002
20. Schnell O: Sympathetic innervation and blood flow in the diabetic heart. In Catecholamine Research: From Molecular Insights to Clinical Practice. Nagatsu T, Nabeshima T, McCarty R, Goldstein DS, Eds. New York, Kluwer Academic/Plenum Publishers, 2002, p. 505-508
21. Hattori N, Rihl J, Bengel FM, Nekolla SG, Standl E, Schwaiger M, Schnell O: Cardiac autonomic dysinnervation and myocardial blood flow in long-term type 1 diabetic patients. Diabet Med 20:375-381, 2003
22. Schnell O, Muhr D, Dresel S, Weiss M, Haslbeck M, Standl E: Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin dependent (type 1) diabetes mellitus at one-year follow-up. Diabet Med 14:57-62, 1997
23. Di Bari M, Marchionni N, Pahor M: Beta-blockers after acute myocardial infarction in elderly patients with diabetes mellitus: time to reassess. Drugs Aging 20:13-22, 2003